Healthcare

In 2026, OIL has drawn fresh chart attention as the company advances a series of regulatory milestones and continues high-profile clinical collaborations. This article reviews why Optiscan Imaging is in focus, the sector context, its potential growth drivers and the risks that accompany a …

Small-cap medical diagnostics names on the ASX have a way of capturing attention when their science edges closer to the clinic, and INOVIQ Limited (ASX:IIQ) has become one of the stocks market participants are following in 2026. The company sits in the fast-evolving field …

Cynata Therapeutics (ASX: CYP) has returned to the attention of biotech-focused investors as its lead late-stage program edges toward a defining data point. The company, a small-cap player in Australia’s regenerative medicine landscape, has spent recent quarters advancing two clinical readouts that could reshape …

For much of the past two decades, CSL Limited (ASX:CSL) was treated by many Australian investors as a benchmark blue-chip growth story, a globally significant biotechnology company that consistently expanded earnings and rewarded long-term holders. That perception has been tested. A sustained period of …

Few categories of the Australian market generate as much speculative interest as small-capitalisation biotechnology, and Cambium Bio Limited (ASX:CMB) is a recent example of how quickly a clinical-stage developer can return to the spotlight. After a sharp move in its share price, CMB has …

Imugene is a clinical-stage immuno-oncology company focused on developing therapies designed to harness the immune system to target and treat cancer. Historically, the company built a diversified pipeline spanning several modalities, including B-cell immunotherapy vaccines such as HER-Vaxx and PD1-Vaxx, oncolytic virus candidates including …

For market participants tracking the diagnostics theme, Lumos Diagnostics offers a case study in how a single regulatory catalyst can reshape sentiment around a small-cap stock — and how quickly that sentiment can swing in both directions. This article looks at why LDX is …